Impact of mirikizumab therapy on histologic measures of intestinal inflammation in a Phase 2 study of patients with moderately to severely active Crohn’s disease
Zeitschrift für Gastroenterologie | June 13, 2023 | Volume: 61 | Issue: 05 | Pages: e183-e184
10.1055/s-0043-1769022